Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Naresh Mandava

Concepts (360)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
21
2023
151
5.320
 Why?
Geographic Atrophy
7
2023
49
2.380
 Why?
Visual Acuity
18
2023
273
2.270
 Why?
Retinal Detachment
6
2023
54
2.240
 Why?
Diabetic Retinopathy
11
2023
160
2.060
 Why?
Wet Macular Degeneration
5
2023
32
1.900
 Why?
Angiogenesis Inhibitors
17
2023
219
1.880
 Why?
Retinal Drusen
3
2021
25
1.740
 Why?
Registries
4
2020
1810
1.320
 Why?
Vitreous Body
15
2022
104
1.230
 Why?
Vitrectomy
12
2020
58
1.190
 Why?
Macula Lutea
2
2023
15
1.130
 Why?
Retina
10
2021
278
0.970
 Why?
Retinal Diseases
4
2023
81
0.910
 Why?
Antibodies, Monoclonal
9
2011
1285
0.900
 Why?
Vascular Endothelial Growth Factor A
12
2023
527
0.900
 Why?
Retinal Neovascularization
2
2019
21
0.830
 Why?
Choroidal Neovascularization
6
2019
44
0.810
 Why?
Fluorescein Angiography
15
2023
103
0.790
 Why?
National Eye Institute (U.S.)
1
2020
6
0.780
 Why?
Retinal Perforations
4
2015
14
0.760
 Why?
Quarantine
1
2020
25
0.750
 Why?
Estrogen Replacement Therapy
1
2019
117
0.670
 Why?
Retinitis Pigmentosa
3
2021
17
0.650
 Why?
Tomography, Optical Coherence
10
2022
126
0.650
 Why?
Intraocular Pressure
6
2012
275
0.580
 Why?
Automobile Driving
1
2018
128
0.580
 Why?
Epiretinal Membrane
3
2010
6
0.580
 Why?
Aged, 80 and over
15
2021
6562
0.560
 Why?
Aged
27
2023
19661
0.560
 Why?
Scleral Buckling
3
2019
18
0.540
 Why?
Antibodies, Monoclonal, Humanized
11
2015
667
0.510
 Why?
Self Report
1
2018
699
0.500
 Why?
Optic Neuropathy, Ischemic
3
2013
29
0.490
 Why?
Humans
76
2023
119032
0.490
 Why?
Recombinant Fusion Proteins
4
2013
653
0.460
 Why?
Female
46
2023
61588
0.460
 Why?
Choroid
5
2021
47
0.460
 Why?
Surveys and Questionnaires
4
2022
4709
0.460
 Why?
Retinopathy of Prematurity
3
2020
111
0.450
 Why?
Bevacizumab
11
2015
124
0.440
 Why?
Research Design
1
2019
969
0.440
 Why?
Follow-Up Studies
13
2021
4596
0.440
 Why?
Male
44
2023
57818
0.430
 Why?
Retinal Necrosis Syndrome, Acute
2
2013
9
0.420
 Why?
Pandemics
1
2020
1355
0.420
 Why?
Retinal Vein Occlusion
2
2015
13
0.420
 Why?
Photography
4
2015
93
0.410
 Why?
Endophthalmitis
3
2017
25
0.400
 Why?
Uveal Diseases
2
2013
5
0.400
 Why?
Cataract
2
2020
194
0.380
 Why?
Middle Aged
28
2021
27627
0.380
 Why?
Diagnostic Techniques, Ophthalmological
2
2015
36
0.380
 Why?
Colorado
7
2023
4196
0.370
 Why?
Complement Factor B
2
2022
102
0.360
 Why?
Visual Fields
3
2022
78
0.360
 Why?
Glycogen Storage Disease Type IIb
2
2007
20
0.360
 Why?
Vision, Low
4
2022
14
0.350
 Why?
Pigment Epithelium of Eye
2
2006
34
0.340
 Why?
Prospective Studies
7
2023
6477
0.340
 Why?
Injections
6
2010
167
0.340
 Why?
Complement Activation
3
2022
350
0.340
 Why?
Ophthalmology
2
2013
80
0.330
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1185
0.330
 Why?
Retrospective Studies
22
2023
12990
0.330
 Why?
Ocular Hypertension
1
2009
60
0.320
 Why?
Proliferating Cell Nuclear Antigen
1
2007
55
0.310
 Why?
Vitreoretinopathy, Proliferative
1
2007
12
0.310
 Why?
Optic Nerve Injuries
1
2007
4
0.310
 Why?
Macular Edema
2
2015
36
0.300
 Why?
Phacoemulsification
3
2020
103
0.300
 Why?
Quantum Dots
2
2021
34
0.300
 Why?
Encephalitis, Herpes Simplex
1
2007
23
0.300
 Why?
Vision Disorders
2
2022
135
0.300
 Why?
Papilledema
1
2007
36
0.300
 Why?
von Hippel-Lindau Disease
1
2007
12
0.300
 Why?
Fovea Centralis
2
2010
8
0.300
 Why?
Puerperal Disorders
1
2007
33
0.290
 Why?
Glucocorticoids
2
2013
547
0.290
 Why?
RNA, Catalytic
1
2007
182
0.290
 Why?
Triamcinolone Acetonide
1
2006
24
0.280
 Why?
Herpesvirus 1, Human
1
2007
81
0.280
 Why?
Ocular Hypotension
1
2006
10
0.280
 Why?
Ciliary Body
1
2006
33
0.280
 Why?
Myopia
1
2006
37
0.270
 Why?
Telangiectasis
1
2005
6
0.270
 Why?
Granuloma
1
2006
87
0.270
 Why?
Chemokine CCL5
2
2023
48
0.270
 Why?
Retinal Vessels
1
2005
53
0.260
 Why?
DNA, Viral
1
2007
356
0.260
 Why?
Retinal Ganglion Cells
4
2022
92
0.260
 Why?
Laser Therapy
2
2021
104
0.250
 Why?
Diabetes Mellitus
2
2023
945
0.250
 Why?
Vision Tests
1
2023
15
0.240
 Why?
Fluorocarbons
1
2005
105
0.240
 Why?
Temporal Arteries
2
2015
47
0.230
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2013
103
0.230
 Why?
Disease Models, Animal
4
2012
3730
0.220
 Why?
Hemianopsia
1
2022
10
0.220
 Why?
Risk Factors
9
2023
9003
0.210
 Why?
Optic Disk
3
2010
36
0.210
 Why?
Ophthalmoscopy
2
2015
30
0.210
 Why?
Posterior Capsulotomy
1
2021
8
0.200
 Why?
Posterior Capsule of the Lens
1
2021
11
0.200
 Why?
Lasers, Solid-State
1
2021
23
0.200
 Why?
Cross-Sectional Studies
4
2020
4552
0.200
 Why?
Capsule Opacification
1
2021
27
0.200
 Why?
Complement System Proteins
2
2022
294
0.190
 Why?
Sickness Impact Profile
1
2020
51
0.190
 Why?
Ranibizumab
5
2013
18
0.190
 Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.190
 Why?
Neurodegenerative Diseases
1
2022
99
0.190
 Why?
Nerve Fibers
2
2010
89
0.180
 Why?
Intravitreal Injections
6
2020
46
0.180
 Why?
Herpesvirus 3, Human
2
2015
389
0.180
 Why?
Electrodes, Implanted
2
2018
97
0.180
 Why?
Protective Factors
1
2019
92
0.180
 Why?
C-Reactive Protein
1
2021
364
0.170
 Why?
Odds Ratio
2
2019
996
0.170
 Why?
Ischemia
2
2017
374
0.170
 Why?
Complement Membrane Attack Complex
1
2019
35
0.170
 Why?
Complement C3a
1
2019
33
0.170
 Why?
Intraoperative Complications
1
2020
132
0.170
 Why?
Biomarkers
4
2023
3590
0.170
 Why?
Visual Prosthesis
1
2018
1
0.170
 Why?
Quality of Life
4
2022
2369
0.170
 Why?
Cohort Studies
5
2020
5117
0.160
 Why?
Postoperative Complications
3
2021
2235
0.160
 Why?
Orbit
2
2010
59
0.160
 Why?
Metformin
1
2021
295
0.150
 Why?
Reproducibility of Results
2
2023
2874
0.150
 Why?
Anterior Eye Segment
1
2017
10
0.150
 Why?
Labor, Induced
1
2017
30
0.150
 Why?
Strabismus
1
2017
27
0.150
 Why?
Fetal Membranes, Premature Rupture
1
2017
38
0.150
 Why?
Laser Coagulation
3
2012
55
0.150
 Why?
Labor, Obstetric
1
2017
53
0.150
 Why?
Giant Cell Arteritis
2
2015
47
0.140
 Why?
Time Factors
4
2021
6414
0.140
 Why?
Ophthalmologic Surgical Procedures
1
2017
60
0.140
 Why?
Retinal Degeneration
2
2015
31
0.140
 Why?
Immunosuppressive Agents
2
2013
683
0.140
 Why?
Blindness
3
2013
35
0.140
 Why?
Phenotype
3
2022
3004
0.140
 Why?
Recovery of Function
1
2019
604
0.130
 Why?
Gyrate Atrophy
1
2015
2
0.130
 Why?
Case-Control Studies
2
2020
3173
0.130
 Why?
Incidence
2
2020
2424
0.130
 Why?
Vitreoretinal Surgery
1
2015
3
0.130
 Why?
Eye Infections, Bacterial
1
2015
26
0.130
 Why?
Vitreous Detachment
1
2015
6
0.130
 Why?
Treatment Outcome
7
2021
9346
0.130
 Why?
Encephalitis, Varicella Zoster
1
2015
20
0.130
 Why?
Needles
1
2015
56
0.130
 Why?
Multivariate Analysis
1
2019
1474
0.130
 Why?
Wounds, Gunshot
2
2010
176
0.130
 Why?
Biopsy, Needle
1
2015
190
0.130
 Why?
Antiviral Agents
2
2013
654
0.130
 Why?
Oculomotor Muscles
1
2014
42
0.130
 Why?
Inflammation
3
2023
2571
0.130
 Why?
Rats, Inbred BN
3
2011
53
0.120
 Why?
Proteomics
1
2020
876
0.120
 Why?
Logistic Models
1
2019
1901
0.120
 Why?
Fundus Oculi
3
2014
41
0.120
 Why?
Proteins
1
2020
938
0.120
 Why?
Adult
15
2020
31525
0.120
 Why?
Fibrin
1
2014
60
0.120
 Why?
Anti-Inflammatory Agents
2
2021
467
0.120
 Why?
Uvea
1
2013
2
0.120
 Why?
Exchange Transfusion, Whole Blood
1
2013
18
0.120
 Why?
Uveomeningoencephalitic Syndrome
1
2013
6
0.120
 Why?
Drug Packaging
2
2011
44
0.120
 Why?
Retinal Artery Occlusion
1
2013
8
0.120
 Why?
Drug Resistance, Multiple, Viral
1
2013
11
0.120
 Why?
Cytomegalovirus Retinitis
1
2013
13
0.120
 Why?
Premature Birth
1
2017
284
0.120
 Why?
Tendons
1
2014
137
0.110
 Why?
Lymphoproliferative Disorders
1
2013
46
0.110
 Why?
Isoxazoles
1
2013
56
0.110
 Why?
Retinal Pigment Epithelium
1
2013
60
0.110
 Why?
Fatty Acids, Omega-3
1
2014
125
0.110
 Why?
Silicon
1
2012
14
0.110
 Why?
Lens Subluxation
1
2012
3
0.110
 Why?
Viremia
1
2013
132
0.110
 Why?
Trabecular Meshwork
1
2013
75
0.110
 Why?
Uveitis, Posterior
1
2012
12
0.110
 Why?
Exanthema
1
2013
77
0.110
 Why?
Diagnostic Imaging
1
2015
294
0.100
 Why?
Placenta
1
2018
641
0.100
 Why?
Fluocinolone Acetonide
1
2012
16
0.100
 Why?
Microsurgery
1
2012
64
0.100
 Why?
Diagnosis, Differential
4
2013
1384
0.100
 Why?
Gestational Age
3
2020
765
0.100
 Why?
Electric Stimulation Therapy
1
2012
74
0.100
 Why?
Particulate Matter
2
2011
244
0.100
 Why?
Global Health
1
2014
310
0.100
 Why?
Vascular Endothelial Growth Factors
1
2011
67
0.100
 Why?
Fluorescein-5-isothiocyanate
2
2009
38
0.100
 Why?
Electroretinography
2
2012
41
0.100
 Why?
Silicone Oils
1
2011
25
0.100
 Why?
Drug Storage
1
2011
59
0.100
 Why?
Dextrans
2
2009
74
0.100
 Why?
Glaucoma
2
2010
202
0.100
 Why?
Dissection
1
2011
55
0.090
 Why?
Health Care Costs
1
2014
394
0.090
 Why?
Infliximab
2
2007
94
0.090
 Why?
Anemia, Sickle Cell
1
2013
230
0.090
 Why?
Antioxidants
1
2014
564
0.090
 Why?
Lysosomal-Associated Membrane Protein 2
2
2007
24
0.090
 Why?
Protein Multimerization
1
2011
161
0.090
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
387
0.090
 Why?
Clinical Trials, Phase II as Topic
1
2009
57
0.090
 Why?
Clinical Trials, Phase I as Topic
1
2009
47
0.090
 Why?
United States
3
2020
12557
0.090
 Why?
Tonometry, Ocular
1
2009
83
0.080
 Why?
Bacteria
1
2015
757
0.080
 Why?
Herpes Zoster
1
2013
336
0.080
 Why?
Scotoma
1
2008
4
0.080
 Why?
Rats
4
2012
5394
0.080
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
256
0.080
 Why?
Retinal Artery
1
2007
15
0.080
 Why?
Vitreous Hemorrhage
1
2007
6
0.080
 Why?
Cerebral Angiography
1
2007
116
0.080
 Why?
Acyclovir
1
2007
105
0.070
 Why?
Frameshift Mutation
1
2006
28
0.070
 Why?
Dose-Response Relationship, Drug
2
2009
1947
0.070
 Why?
Indocyanine Green
1
2005
13
0.070
 Why?
Conjunctival Neoplasms
1
2005
7
0.070
 Why?
Secondary Prevention
1
2007
227
0.070
 Why?
beta-Thalassemia
1
2006
23
0.070
 Why?
Internationality
2
2018
152
0.070
 Why?
Eye Injuries, Penetrating
1
2005
17
0.070
 Why?
Ultrasonography
2
2007
716
0.070
 Why?
Coloring Agents
1
2005
73
0.070
 Why?
Eye Foreign Bodies
1
2005
23
0.070
 Why?
Eye Injuries
1
2006
46
0.070
 Why?
Antihypertensive Agents
1
2009
438
0.070
 Why?
Uveitis
1
2006
116
0.070
 Why?
Staining and Labeling
1
2005
146
0.070
 Why?
Pregnancy
3
2018
5694
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2007
1175
0.070
 Why?
Metals
1
2005
111
0.060
 Why?
Mydriatics
1
2004
3
0.060
 Why?
Pupil
1
2004
13
0.060
 Why?
Polymerase Chain Reaction
1
2007
1012
0.060
 Why?
Sclera
2
2014
36
0.060
 Why?
Young Adult
6
2019
10799
0.060
 Why?
Hospitals, County
1
2023
11
0.060
 Why?
Animals
6
2014
33399
0.060
 Why?
Sensitivity and Specificity
2
2008
1795
0.060
 Why?
Cardiomyopathy, Dilated
1
2007
344
0.060
 Why?
Observer Variation
1
2004
309
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
2
2019
827
0.060
 Why?
Double-Blind Method
1
2007
1687
0.060
 Why?
Autoimmune Diseases
1
2006
398
0.060
 Why?
Complement Factor I
1
2022
12
0.050
 Why?
Interleukin-4
1
2023
216
0.050
 Why?
Aqueous Humor
1
2022
31
0.050
 Why?
Albumins
1
2022
100
0.050
 Why?
Retreatment
2
2012
71
0.050
 Why?
Fibrinogen
1
2022
161
0.050
 Why?
Lenses, Intraocular
1
2021
45
0.050
 Why?
Drug Compounding
2
2011
90
0.050
 Why?
Equipment Design
2
2014
519
0.050
 Why?
Electric Stimulation
1
2021
268
0.050
 Why?
Immunologic Factors
1
2022
225
0.050
 Why?
Chronic Disease
1
2006
1637
0.040
 Why?
RNA, Messenger
1
2007
2661
0.040
 Why?
Cell Survival
2
2013
1047
0.040
 Why?
Melanoma
1
2005
664
0.040
 Why?
Postoperative Period
1
2019
309
0.040
 Why?
Infant
3
2020
8295
0.040
 Why?
Immunity, Maternally-Acquired
1
2018
24
0.040
 Why?
Prevalence
2
2015
2326
0.040
 Why?
Primary Health Care
1
2008
1560
0.040
 Why?
Infant, Newborn
2
2020
5256
0.040
 Why?
Combined Modality Therapy
2
2013
1167
0.040
 Why?
Referral and Consultation
1
2022
648
0.040
 Why?
Iris Diseases
1
2017
5
0.040
 Why?
Choroid Diseases
1
2017
9
0.040
 Why?
Birth Weight
1
2020
465
0.040
 Why?
Parity
1
2017
101
0.040
 Why?
Sex Characteristics
1
2022
671
0.040
 Why?
Prosthesis Implantation
1
2018
141
0.040
 Why?
Mental Health
1
2022
568
0.040
 Why?
Infant, Low Birth Weight
1
2017
125
0.040
 Why?
Microbiological Techniques
1
2015
31
0.030
 Why?
Myopia, Degenerative
1
2015
3
0.030
 Why?
Colony Count, Microbial
1
2015
120
0.030
 Why?
Endotamponade
1
2015
4
0.030
 Why?
Adolescent
3
2012
18483
0.030
 Why?
Risk
1
2018
854
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
31
0.030
 Why?
Cerebral Arterial Diseases
1
2015
43
0.030
 Why?
Disease Progression
2
2015
2490
0.030
 Why?
Atrophy
1
2015
164
0.030
 Why?
Biometry
1
2014
65
0.030
 Why?
Conjunctiva
1
2014
52
0.030
 Why?
Lens Implantation, Intraocular
1
2015
60
0.030
 Why?
T-Lymphocytes
1
2022
1774
0.030
 Why?
Fetus
1
2018
690
0.030
 Why?
Hypoglycemic Agents
1
2021
1035
0.030
 Why?
Infant, Premature
1
2017
480
0.030
 Why?
Early Diagnosis
1
2014
230
0.030
 Why?
Safety-net Providers
1
2014
96
0.030
 Why?
Child, Preschool
1
2007
9493
0.030
 Why?
Adaptation, Ocular
1
2012
4
0.030
 Why?
Dark Adaptation
1
2012
13
0.030
 Why?
Rats, Mutant Strains
1
2012
25
0.030
 Why?
Sclerostomy
1
2012
4
0.030
 Why?
Cytomegalovirus
1
2013
144
0.030
 Why?
Mothers
1
2018
683
0.030
 Why?
Drug Implants
1
2012
72
0.030
 Why?
Cell Count
1
2012
315
0.030
 Why?
Gold
1
2012
102
0.030
 Why?
Bruch Membrane
1
2011
6
0.030
 Why?
Swine
1
2014
731
0.020
 Why?
Polyglycolic Acid
1
2011
44
0.020
 Why?
Miniaturization
1
2011
24
0.020
 Why?
Administration, Oral
1
2013
756
0.020
 Why?
Drug Stability
1
2011
153
0.020
 Why?
Delayed-Action Preparations
1
2011
161
0.020
 Why?
Immunoglobulin Light Chains
1
2010
35
0.020
 Why?
Chromatography, Gel
1
2010
133
0.020
 Why?
Immunoglobulin Heavy Chains
1
2010
72
0.020
 Why?
Fluorescein
1
2010
27
0.020
 Why?
Molecular Weight
1
2010
343
0.020
 Why?
Comorbidity
1
2015
1527
0.020
 Why?
Aptamers, Nucleotide
1
2010
74
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2010
332
0.020
 Why?
Particle Size
1
2011
345
0.020
 Why?
Microfluidic Analytical Techniques
1
2010
75
0.020
 Why?
Lactic Acid
1
2011
282
0.020
 Why?
Reference Values
1
2010
775
0.020
 Why?
Poverty Areas
1
2008
35
0.020
 Why?
Fibroblasts
1
2013
843
0.020
 Why?
Optic Nerve Diseases
1
2008
32
0.020
 Why?
Community Health Centers
1
2008
57
0.020
 Why?
Fluorescent Dyes
1
2010
316
0.020
 Why?
Kaplan-Meier Estimate
1
2010
842
0.020
 Why?
Models, Biological
1
2015
1715
0.020
 Why?
Pilot Projects
1
2012
1420
0.020
 Why?
Kidney Transplantation
1
2013
585
0.020
 Why?
Imaging, Three-Dimensional
1
2010
499
0.020
 Why?
Polyethylene Glycols
1
2011
578
0.020
 Why?
Anti-Bacterial Agents
1
2015
1517
0.020
 Why?
Image Processing, Computer-Assisted
1
2010
710
0.020
 Why?
Pedigree
1
2007
485
0.020
 Why?
Infusions, Intravenous
1
2006
380
0.020
 Why?
Cells, Cultured
1
2013
4081
0.020
 Why?
Adrenal Cortex Hormones
1
2008
521
0.020
 Why?
Severity of Illness Index
1
2011
2674
0.010
 Why?
Mass Screening
1
2008
1052
0.010
 Why?
Tomography, X-Ray Computed
1
2010
2436
0.010
 Why?
Risk Assessment
1
2008
3057
0.010
 Why?
Diabetes Mellitus, Type 2
1
2012
2179
0.010
 Why?
Aging
1
2008
1677
0.010
 Why?
Mutation
1
2007
3457
0.010
 Why?
Child
1
2012
19137
0.010
 Why?
Mandava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (360) concept(s)
_
Co-Authors Expand Description
See all (43) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)